Antimicrobial resistance in more than 100,000 Escherichia coli isolates according to culture site and patient age, gender, and location

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 3, 2011, Pages 1222-1228

  Sahuquillo Arce, José Miguel ^a   Selva, María ^b   Perpiñán, Hèctor ^c,d   Gobernado, Miguel ^a   Armero, Carmen ^d   López Quílez, Antonio ^d   González, Francisco ^b   Vanaclocha, Hermelinda ^b  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b Direccion General de Salud Publica   (Spain)

^c UNIVERSIDAD SAN PABLO CEU   (Spain)

^d UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFOTAXIME; CEFOXITIN; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; FOSFOMYCIN; IMIPENEM; NITROFURANTOIN; TOBRAMYCIN;

ADAPTATION; AGE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BAYES THEOREM; ESCHERICHIA COLI; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONTE CARLO METHOD; NONHUMAN; PREGNANCY; PREMENOPAUSE; PRIORITY JOURNAL; RESPIRATORY SYSTEM; SEX DIFFERENCE; SKIN; SOFT TISSUE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMIKACIN; AMPICILLIN; ANTI-BACTERIAL AGENTS; CEFOTAXIME; CHILD; CHILD, PRESCHOOL; CIPROFLOXACIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FOSFOMYCIN; HUMANS; IMIPENEM; INFANT; MALE; MIDDLE AGED; NITROFURANTOIN; RETROSPECTIVE STUDIES; TOBRAMYCIN; YOUNG ADULT;

EID: 79952327300     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00765-10     Document Type: Article

References (39)

1. Alós, J. I., P. García-Peña, and J. Tamayo. 2007. Biological cost associated with fosfomycin resistance in Escherichia coli isolates from urinary tract infections. Rev. Esp. Quimioter. 20:211-215. (In Spanish.)
2. Antão, E. M., L. H. Wieler, and C. Ewers. 2009. Adhesive threads of extraintestinal pathogenic Escherichia coli. Gut Pathog. 1:22.
3. Bansal, T., et al. 2007. Differential effects of epinephrine, norepinephrine, and indole on Escherichia coli O157:H7 chemotaxis, colonization, and gene expression. Infect. Immun. 75:4597-4607.
4. Boyd, L. B., et al. 2008. Increased fluoroquinolone resistance with time in Escherichia coli from >17,000 patients at a large county hospital as a function of culture site, age, sex, and location. BMC Infect. Dis. 8:4. doi:10.1186/1471-2334-8-4.
5. Bukh, A. S., et al. 2009. Escherichia coli phylogenetic groups are associated with site of infection and level of antibiotic resistance in community-acquired bacteraemia: a 10 year population-based study in Denmark. J. Antimicrob. Chemother. 64:163-168.
6. Burnham, K. P., and D. R. Anderson. 2002. Model selection and multi-model inference: a practical information theoretic approach. Springer-Verlag, New York, NY.
7. Croxen, M. A., and B. B. Finlay. 2010. Molecular mechanisms of Escherichia coli pathogenicity. Nat. Rev. Microbiol. 8:26-38.
8. Duriez, P., et al. 2001. Commensal Escherichia coli isolates are phylogenetically distributed among geographically distinct human populations. Microbiology 147:1671-1676.
9. Elhanan, G., H. Tabenkin, R. Yahalom, and R. Raz. 1994. Single-dose fosfomycin trometamol versus 5-day cephalexin regimen for treatment of uncomplicated lower urinary tract infections in women. Antimicrob. Agents Chemother. 38:2612-2614.
10. Escobar-Páramo, P., et al. 2004. Large-scale population structure of human commensal Escherichia coli isolates. Appl. Environ. Microbiol. 70:5698-5700.
11. Fantin, B., et al. 2009. Ciprofloxacin dosage and emergence of resistance in human commensal bacteria. J. Infect. Dis. 200:390-398.
12. Gelfand, A. E., and A. F. M. Smith. 1990. Sampling-based approaches to calculating marginal densities. J. Am. Stat. Assoc. 85:398-410.
13. González Morán, F., I. Muñoz Criado, and H. Vanaclocha. 2008. La información en tiempo real: una herramienta necesaria en vigilancia epidemiológica. Gac. Sanit. 22:162-167.
14. Gordon, D. M., S. E. Stern, and P. J. Collignon. 2005. Influence of the age and sex of human hosts on the distribution of Escherichia coli ECOR groups and virulence traits. Microbiology 151:15-23.
15. Harrison, J. J., et al. 2009. The chromosomal toxin gene yafQ is a determinant of multidrug tolerance for Escherichia coli growing in a biofilm. Antimicrob. Agents Chemother. 53:2253-2258.
16. Hegde, M., T. K. Wood, and A. Jayaraman. 2009. The neuroendocrine hormone norepinephrine increases Pseudomonas aeruginosa PA14 virulence through the las quorum-sensing pathway. Appl. Microbiol. Biotechnol. 84:763-776.
17. Ito, A., A. Taniuchi, T. May, K. Kawata, and S. Okabe. 2009. Increased antibiotic resistance of Escherichia coli in mature biofilms. Appl. Environ. Microbiol. 75:4093-4100.
18. Johnson, J. R., et al. 2005. Phylogenetic and pathotypic comparison of concurrent urine and rectal Escherichia coli isolates from men with febrile urinary tract infection. J. Clin. Microbiol. 43:3895-3900.
19. Lee, J., et al. 2008. Indole cell signaling occurs primarily at low temperatures in Escherichia coli. ISME J. 2:1007-1023.
20. Le Gall, T., et al. 2007. Extraintestinal virulence is a coincidental by-product of commensalism in B2 phylogenetic group Escherichia coli strains. Mol. Biol. Evol. 24:2373-2384. (Pubitemid 350060443)
21. Livermore, D. M., et al. 2003. Ciprofloxacin-resistant Escherichia coli from bacteraemias in England; increasingly prevalent and mostly from men. J. Antimicrob. Chemother. 52:1040-1042.
22. López, E., M. Elez, I. Matic, and J. Blázquez. 2007. Antibiotic-mediated recombination: ciprofloxacin stimulates SOS-independent recombination of divergent sequences in Escherichia coli. Mol. Microbiol. 64:83-93. (Pubitemid 46435037)
23. Moodley, A., and L. Guardabassi. 2009. Transmission of IncN plasmids carrying blaCTX-M-1 between commensal Escherichia coli in pigs and farm workers. Antimicrob. Agents Chemother. 53:1709-1711.
24. Muñoz, I., H. Vanaclocha, and F. González. 2007. The importance of microbiological surveillance networks in monitoring resistant bacteria. Red-MIVA. Rev. Esp. Quimioter. 20:193-202.
25. Muñoz, I., H. Vanaclocha, M. Martín-Sierra, and F. González. 2008. Microbiological Surveillance Network in the Valencian community. Enferm. Infecc. Microbiol. Clin. 26:77-81. (In Spanish.)
26. Pedrera, V., et al. 2004. Analysis of antibiotic use in the community of Valencia (2000-2002). Enferm. Infecc. Microbiol. Clin. 22:385-389. (In Spanish.)
27. Petkovsek, Z., K. Elersic, M. Gubina, D. Zgur-Bertok, and M. Starcic Erjavec. 2009. Virulence potential of Escherichia coli isolates from skin and soft tissue infections. J. Clin. Microbiol. 47:1811-1817.
28. Plotkin, B. J., R. J. Roose, Q. Erikson, and S. M. Viselli. 2003. Effect of androgens and glucocorticoids on microbial growth and antimicrobial susceptibility. Curr. Microbiol. 47:514-520.
29. Quentin, C., et al. 2004. Antibiotic resistance rates and phenotypes in isolates of Enterobacteriaceae in French extrahospital practice. Eur. J. Clin. Microbiol. Infect. Dis. 23:185-193.
30. Sandegren, L., A. Lindqvist, G. Kahlmeter, and D. I. Andersson. 2008. Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli. J. Antimicrob. Chemother. 62:495-503.
31. Schaechter, M., and the View From Here Group. 2001. Escherichia coli and Salmonella 2000: the view from here. Microbiol. Mol. Biol. Rev. 65:119-130.
32. Souza, V., M. Rocha, A. Valera, and L. E. Eguiarte. 1999. Genetic structure of natural populations of Escherichia coli in wild hosts on different continents. Appl. Environ. Microbiol. 65:3373-3385.
33. Spiegelhalter, D. J., N. G. Best, B. P. Carlin, and A. Van der Linde. 2002. Bayesian measures of model complexity and fit (with discussion). J. R. Stat. Soc. B Stat. Methodol. 64:583-616.
34. Spiegelhalter, D., A. Thomas, N. Best, and D. Lunn. 2003. WinBUGS user manual, version 1.4. MRC Biostatistics Unit, Cambridge, United Kingdom. www.mrc-bsu.cam.ac.uk/bugs/winbugs/manual14.pdf.
35. Stewart, P. S. 1996. Theoretical aspects of antibiotic diffusion into microbial biofilms. Antimicrob. Agents Chemother. 40:2517-2522.
36. Tenaillon, O., D. Skurnik, B. Picard, and E. Denamur. 2010. The population genetics of commensal Escherichia coli. Nat. Rev. Microbiol. 8:207-217.
37. Walk, S. T., et al. 2007. Influence of antibiotic selection on genetic composition of Escherichia coli populations from conventional and organic dairy farms. Appl. Environ. Microbiol. 73:5982-5989.
38. Wang, X., et al. 2006. Impact of biofilm matrix components on interaction of commensal Escherichia coli with the gastrointestinal cell line HT-29. Cell. Mol. Life Sci. 63:2352-2363.
39. Yagci, D., F. Yoruk, A. Azap, and O. Memikoglu. 2009. Prevalence and risk factors for selection of quinolone resistance Escherichia coli strains in fecal flora of patients receiving quinolone therapy. Antimicrob. Agents Chemother. 53:1287-1289.